SK18902000A3 - Terapeutické kombinácie (selektívnych) modulátorov estrogénneho receptora (serm) a prostriedkov podporujúcich sekréciu rastového hormónu (ghs) na liečbu muskuloskeletárnej fragility - Google Patents

Terapeutické kombinácie (selektívnych) modulátorov estrogénneho receptora (serm) a prostriedkov podporujúcich sekréciu rastového hormónu (ghs) na liečbu muskuloskeletárnej fragility Download PDF

Info

Publication number
SK18902000A3
SK18902000A3 SK1890-2000A SK18902000A SK18902000A3 SK 18902000 A3 SK18902000 A3 SK 18902000A3 SK 18902000 A SK18902000 A SK 18902000A SK 18902000 A3 SK18902000 A3 SK 18902000A3
Authority
SK
Slovakia
Prior art keywords
compound
oxo
ethyl
phenyl
pyridin
Prior art date
Application number
SK1890-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SK18902000A3 publication Critical patent/SK18902000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1890-2000A 1998-06-16 1999-05-03 Terapeutické kombinácie (selektívnych) modulátorov estrogénneho receptora (serm) a prostriedkov podporujúcich sekréciu rastového hormónu (ghs) na liečbu muskuloskeletárnej fragility SK18902000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (fr) 1998-06-16 1999-05-03 Combinaisons therapeutiques de modulateurs (selectifs) des recepteurs des oestrogenes (serm) et de secretagogues d'hormones de croissance (ghs) pour traiter la fragilite musculo-squelettique

Publications (1)

Publication Number Publication Date
SK18902000A3 true SK18902000A3 (sk) 2001-12-03

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1890-2000A SK18902000A3 (sk) 1998-06-16 1999-05-03 Terapeutické kombinácie (selektívnych) modulátorov estrogénneho receptora (serm) a prostriedkov podporujúcich sekréciu rastového hormónu (ghs) na liečbu muskuloskeletárnej fragility

Country Status (29)

Country Link
EP (1) EP1085867A1 (fr)
JP (1) JP2002518328A (fr)
KR (1) KR20010052817A (fr)
CN (1) CN1305378A (fr)
AP (1) AP9901581A0 (fr)
AR (1) AR018868A1 (fr)
AU (1) AU3342099A (fr)
BG (1) BG105128A (fr)
BR (1) BR9911357A (fr)
CA (1) CA2335112A1 (fr)
CO (1) CO5070586A1 (fr)
EA (1) EA200001189A1 (fr)
GT (1) GT199900083A (fr)
HR (1) HRP20000857A2 (fr)
HU (1) HUP0102395A2 (fr)
ID (1) ID26726A (fr)
IL (1) IL139587A0 (fr)
IS (1) IS5727A (fr)
MA (1) MA26648A1 (fr)
NO (1) NO20006381D0 (fr)
OA (1) OA11569A (fr)
PA (1) PA8472101A1 (fr)
PE (1) PE20000633A1 (fr)
PL (1) PL345064A1 (fr)
SK (1) SK18902000A3 (fr)
TN (1) TNSN99118A1 (fr)
UY (1) UY25557A1 (fr)
WO (1) WO1999065488A1 (fr)
ZA (1) ZA993973B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (fr) * 1998-08-06 2000-06-07 Pfizer Products Inc. Agonistes/antagonistes de l'estrogène
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
ES2319785T3 (es) * 2001-11-29 2009-05-12 Gtx, Inc. Prevencion y tratamiento de osteoporosis inducida por privacion de androgenos.
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EA200901077A1 (ru) 2007-02-09 2010-04-30 Транзим Фарма, Инк. Макроциклические модуляторы грелинового рецептора и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
UY25557A1 (es) 2001-01-31
PA8472101A1 (es) 2000-09-29
ID26726A (id) 2001-02-01
EP1085867A1 (fr) 2001-03-28
IS5727A (is) 2000-11-24
WO1999065488A1 (fr) 1999-12-23
PL345064A1 (en) 2001-11-19
TNSN99118A1 (fr) 2005-11-10
EA200001189A1 (ru) 2001-06-25
JP2002518328A (ja) 2002-06-25
PE20000633A1 (es) 2000-07-26
BG105128A (en) 2001-11-30
BR9911357A (pt) 2001-03-13
HUP0102395A2 (hu) 2001-11-28
KR20010052817A (ko) 2001-06-25
AP9901581A0 (en) 1999-06-30
IL139587A0 (en) 2002-02-10
HRP20000857A2 (en) 2001-10-31
NO20006381L (no) 2000-12-14
OA11569A (en) 2004-07-01
CN1305378A (zh) 2001-07-25
MA26648A1 (fr) 2004-12-20
CA2335112A1 (fr) 1999-12-23
AU3342099A (en) 2000-01-05
AR018868A1 (es) 2001-12-12
NO20006381D0 (no) 2000-12-14
ZA993973B (en) 2000-12-15
CO5070586A1 (es) 2001-08-28
GT199900083A (es) 2000-12-05

Similar Documents

Publication Publication Date Title
US7632813B2 (en) Bone densifying agent characterized by use of cathepsin K inhibitor with PTH
AP975A (en) Combination therapy for osteoporosis.
PT1414486E (pt) Utilizaã†o de glp-2 em combinaã†o com outro agente terap—utico em perturbaãŽes ësseas
JP2003528135A (ja) 糖尿病のランゲルハンス島シグナリングの改善方法及びその防止方法
JP2000514840A (ja) 成長ホルモン分泌促進物質としての置換ジペプチドの酒石酸塩
KR20140084303A (ko) 소아 담즙울체성 간 질환 치료용 담즙산 재순환 억제제
JPH11180926A (ja) 骨粗しょう症用化合物
SK18902000A3 (sk) Terapeutické kombinácie (selektívnych) modulátorov estrogénneho receptora (serm) a prostriedkov podporujúcich sekréciu rastového hormónu (ghs) na liečbu muskuloskeletárnej fragility
OA11566A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone.
KR19990022498A (ko) 뼈 손실의 최소화 방법
SK18912000A3 (sk) Terapeutické kombinácie obsahujúce selektívny modulátor receptorov estrogénu (serm) a sekretagogum rastového hormónu (ghs) nanie muskuloskeletárnej slabosti
US6284773B1 (en) Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2
CZ20004680A3 (cs) Terapeutické kombinace (selektivních) modulátorů estrogenního receptorů (ŠERM) a prostředků podporujících sekreci růstového hormonu (GHS) pro léčbu muskuloskeletární fragility
MXPA00012628A (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
MacDonald et al. Emerging therapies in osteoporosis
MXPA00012727A (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
MXPA00012728A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
MXPA99005564A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin e2
CZ20004678A3 (cs) Terapeutické kombinace obsahující selektivní modulátor receptorů estrogenů a hormon příštítných tělísek